Honey sweetened yogurt for Obesity

Phase-Based Progress Estimates
ObesityHoney sweetened yogurt - Other
45 - 65
What conditions do you have?

Study Summary

This trial will test the effects of honey-flavored yogurt on inflammation, oxidative stress, and microbial metabolites.

Eligible Conditions
  • Obesity

Treatment Effectiveness

Study Objectives

1 Primary · 8 Secondary · Reporting Duration: 4 weeks

4 weeks
Concentration of CD4+ T Helper (TH)17 cytokines
Concentration of Secondary bile acids
Concentration of Short chain fatty acids
Concentration of soluble NADPH oxidase (NOX2)
Concentration of total Nitrate/Nitrite and Nitric Oxide related metabolites (RSNO)
Concentration of untargeted metabolomics
Concentration of uric acid
Concentration of urolithins and other ellagitannin-derived metabolites
Determination of microbial populations

Trial Safety

Trial Design

2 Treatment Groups

Honey sweetened yogurt
1 of 2
Sugar sweetened yogurt
1 of 2

Experimental Treatment

Non-Treatment Group

20 Total Participants · 2 Treatment Groups

Primary Treatment: Honey sweetened yogurt · Has Placebo Group · N/A

Honey sweetened yogurt
Experimental Group · 1 Intervention: Honey sweetened yogurt · Intervention Types: Other
Sugar sweetened yogurt
PlaceboComparator Group · 1 Intervention: Sugar sweetened yogurt · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 4 weeks

Who is running the clinical trial?

University of California, DavisLead Sponsor
843 Previous Clinical Trials
5,012,331 Total Patients Enrolled
28 Trials studying Obesity
32,919 Patients Enrolled for Obesity
Carl L Keen, PhDPrincipal InvestigatorUniversity of California, Davis; Department of Nutrition
15 Previous Clinical Trials
469 Total Patients Enrolled
1 Trials studying Obesity
21 Patients Enrolled for Obesity

Eligibility Criteria

Age 45 - 65 · Female Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are not menstruating for at least two years.